Park Ha Biological Technology (BYAH) Cash & Equivalents (2023 - 2025)

Park Ha Biological Technology's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• In Q4 2025, Cash & Equivalents changed N/A year-over-year to $3.8 million; the TTM figure through Oct 2025 stood at $3.8 million (changed N/A YoY), while the FY2025 annual figure was $3.8 million, changed N/A from the prior year.
• Cash & Equivalents was $3.8 million for Q4 2025 at Park Ha Biological Technology, up from $547498.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $3.8 million in Q4 2025 to a low of $547498.0 in Q2 2025.
• Historically, Cash & Equivalents has averaged $1.6 million across 3 years, with a median of $1.0 million in 2023.
• Biggest YoY gain for Cash & Equivalents was 47.03% in 2025; the steepest drop was 47.03% in 2025.
• A 3-year view of Cash & Equivalents shows it stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then jumped by 266.44% to $3.8 million in 2025.
• The last three Cash & Equivalents figures came in at $3.8 million (Q4 2025), $547498.0 (Q2 2025), and $1.0 million (Q2 2024), per Business Quant data.